Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, announced the publication of “ ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

From sarcopenia to ALS, researchers are exploring creatine’s broader clinical potential — but more trials are needed to confirm its value.

A new study reveals key predictors of successful weight loss on GLP-1RA drugs like Ozempic and Wegovy, including longer ...

New research shows that signs of Alzheimer’s disease can already be detected in the blood of people as young as their 40s.

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence individuals' weight loss after taking ...

For adults with overweight or obesity, certain factors might influence weight loss after taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs).

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced an oral presentation ...

It is important to catch diseases early on, and prevent further spread and complications. Here are 10 simple and quick tests for men to do, to lead a good-quality life.

Lately, creatine is all over social media, with influencers praising this supplement for everything from building muscle to relieving depression. It has also been lauded for its ability to get rid of ...